Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

A Prospective Randomized Clinical Trial Comparing Menghini-type Needle and Franseen-type Needle for Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Pathological Diagnosis of Sarcoidosis

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.

Who May Be Eligible (Plain English)

Who May Qualify: - -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes - (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical - history, physical exam, and other investigations, and booked for EBUS-TBNA. Who Should NOT Join This Trial: - -Patients that are unable to provide willing to sign a consent form \- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on - clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma, - infection). Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes * (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical * history, physical exam, and other investigations, and booked for EBUS-TBNA. Exclusion Criteria: * -Patients that are unable to provide informed consent \- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on * clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma, * infection).

Treatments Being Tested

DEVICE

endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)

Transbronchial biopsy with Menghini-type or Franseen type Needle

Locations (1)

Toronto General Hospital
Toronto, Ontario, Canada